Suchergebnisse - "Ahn, Eugene R"

PubPharm (44)

1

Sunitinib in Patients With Breast Cancer With FGFR1 or FGFR2 Amplifications or Mutations : Results From the Targeted Agent and Profiling Utilization Registry Study

enthalten in: JCO precision oncology | 2024

von Calfa, C. | Rothe, M. | Mangat, P. | +20

2

Pembrolizumab in Patients With Tumors With High Tumor Mutational Burden : Results From the Targeted Agent and Profiling Utilization Registry Study

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2023

von Duvivier, H. | Rothe, M. | Mangat, P. | +21

3

Cobimetinib Plus Vemurafenib in Patients With Solid Tumors With BRAF Mutations : Results From the Targeted Agent and Profiling Utilization Registry Study

enthalten in: JCO precision oncology | 2023

von Meric-Bernstam, F. | Rothe, M. | Mangat, P. | +20

4

Pertuzumab Plus Trastuzumab in Patients With Lung Cancer With ERBB2 Mutation or Amplification : Results From the Targeted Agent and Profiling Utilization Registry Study

enthalten in: JCO precision oncology | 2023

von Ganti, A. | Rothe, M. | Mangat, P. | +15

5

Pertuzumab Plus Trastuzumab in Patients With Endometrial Cancer With ERBB2/3 Amplification, Overexpression, or Mutation : Results From the TAPUR Study

enthalten in: JCO precision oncology | 2023

von Ahn, E. | Rothe, M. | Mangat, P. | +15

6

Cobimetinib Plus Vemurafenib in Patients With Colorectal Cancer With BRAF Mutations : Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study

enthalten in: JCO precision oncology | 2022

von Klute, K. | Rothe, M. | Garrett-Mayer, E. | +15

7

Pertuzumab Plus Trastuzumab in Patients With Colorectal Cancer With ERBB2 Amplification or ERBB2/3 Mutations : Results From the TAPUR Study

enthalten in: JCO precision oncology | 2022

von Gupta, R. | Meric-Bernstam, F. | Rothe, M. | +8

8

Pembrolizumab in Patients With Metastatic Breast Cancer With High Tumor Mutational Burden : Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2021

von Alva, A. | Mangat, P. | Garrett-Mayer, E. | +17

CommentIn: J Clin Oncol. 2021 Aug 1;39(22):2426-2429. - PMID 33979191

9

Sunitinib in Patients with Metastatic Colorectal Cancer (mCRC) with FLT-3 Amplification : Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study

enthalten in: Targeted oncology | 2020

von Al Baghdadi, T. | Garrett-Mayer, E. | Halabi, S. | +10

10

Palbociclib in Patients With Non-Small-Cell Lung Cancer With CDKN2A Alterations : Results From the Targeted Agent and Profiling Utilization Registry Study

enthalten in: JCO precision oncology | 2020

von Ahn, E. | Mangat, P. | Garrett-Mayer, E. | +16

1
2
3
4
5
Nächster »
[5]